CIRCA THERAPEUTICS
Sparking the next revolution in precise protein degradation
CIRCA Therapeutics is developing ligand-directed targeted protein degraders to address high-value oncology targets. We combine computational design, medicinal chemistry, and translational biology to advance differentiated candidates.
What we do
We develop ligand-directed targeted protein degraders for oncology programs.Computational design to inform warhead and linker selection.Medicinal chemistry to synthesize and optimize candidate series.In vitro biology and mechanistic assays to validate degradation and selectivity.Translational strategy to prioritize programs with clear path to development.
Our Aproach
COOMING SOON
Pipeline
COMING SOON
TEAM
COMING SOON
CONTACT
For partnership, investor, or scientific inquiries, please contact us using the form below
Thank you
Thanks for reaching out. We’ve received your message and will get back to you soon.”